Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Harry Drabkin
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Anatomy
Procedures
Chemicals & Drugs
Concepts & Ideas
Disorders
Living Beings
Devices
Sign-in to see full Profile
Network (preview)
50
Gemmill, Robert M.
26
Roche, Joelle
20
Erickson, Paul
16
Smith, David
9
Varella-Garcia, Marileila
7
Constantin, Bruno
7
Franklin, Wilbur
6
Miller, York
5
Kusy, Sophie
5
Glover, Thomas
5
Costa, Luciano
5
Nasarre, Patrick
5
Potiron, Vincent
4
Rowley, Janet
4
Baron, Anna
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Harry Drabkin (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Konoplev Sergej; Huang Xuelin; Drabkin Harry A; Koeppen Hartmut; Jones Dan; Kantarjian Hagop M; Garcia-Manero Guillermo; Chen Weina; Medeiros L Jeffrey; Bueso-Ramos Carlos E
Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.
Cancer 2009;115(20):4737-44.
-
2009: Cappuzzo Federico; Varella-Garcia Marileila; Rossi Elisa; Gajapathy Sujatha; Valente Marialuisa; Drabkin Harry; Gemmill Robert
MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(4):472-8.
-
2009: Clarhaut Jonathan; Gemmill Robert M; Potiron Vincent A; Ait-Si-Ali Slimane; Imbert Jean; Drabkin Harry A; Roche Joëlle
ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.
Neoplasia (New York, N.Y.) 2009;11(2):157-66.
-
2009: Potiron Vincent A; Roche Joëlle; Drabkin Harry A
Semaphorins and their receptors in lung cancer.
Cancer letters 2009;273(1):1-14.
-
2009: Miura Norimasa; Sato Reina; Tsukamoto Tomoe; Shimizu Mika; Kabashima Hiroko; Takeda Miho; Takahashi Shunsaku; Harada Tomomi; West James E; Drabkin Harry; Mejia Jose E; Shiota Goshi; Murawaki Yoshikazu; Virmani Arvind; Gazdar Adi F; Oshimura Mitsuo; Hasegawa Junichi
A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT.
BMC molecular biology 2009;10():5.
-
2008: Andreeff M; Ruvolo V; Gadgil S; Zeng C; Coombes K; Chen W; Kornblau S; Barón A E; Drabkin H A
HOX expression patterns identify a common signature for favorable AML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(11):2041-7.
-
2008: Ballonoff Ari; Kavanagh Brian; Nash Russell; Drabkin Harry; Trotter James; Costa Luciano; Rabinovitch Rachel
Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.
Acta oncologica (Stockholm, Sweden) 2008;47(5):962-70.
-
2007: Costa Luciano J; Drabkin Harry A
Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies.
The oncologist 2007;12(12):1404-15.
-
2007: Bukowski Ronald M; Kabbinavar Fairooz F; Figlin Robert A; Flaherty Keith; Srinivas Sandy; Vaishampayan Ulka; Drabkin Harry A; Dutcher Janice; Ryba Sarah; Xia Qi; Scappaticci Frank A; McDermott David
Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4536-41.
-
2007: Potiron Vincent A; Sharma Girish; Nasarre Patrick; Clarhaut Jonathan A; Augustin Hellmut G; Gemmill Robert M; Roche Joëlle; Drabkin Harry A
Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Cancer research 2007;67(18):8708-15.
-
2007: Poland Kathryn S; Azim Mohammed; Folsom Matthew; Goldfarb Richard; Naeem Rizwan; Korch Christopher; Drabkin Harry A; Gemmill Robert M; Plon Sharon E
A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.
Genes, chromosomes & cancer 2007;46(9):805-12.
-
2007: Ryan Christopher W; Goldman Bryan H; Lara Primo N; Mack Philip C; Beer Tomasz M; Tangen Catherine M; Lemmon Dianne; Pan Chong-Xian; Drabkin Harry A; Crawford E David;
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3296-301.
-
2007: Brauweiler A; Lorick K L; Lee J P; Tsai Y C; Chan D; Weissman A M; Drabkin H A; Gemmill R M
RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene.
Oncogene 2007;26(16):2263-71.
-
2007: Costa Luciano J; Gemmill Robert M; Drabkin Harry A
Upstream signaling inhibition enhances rapamycin effect on growth of kidney cancer cells.
Urology 2007;69(3):596-602.
-
2006: Xavier Ana C G; Marshall Carrie; La Rosa Francisco G; Costa Luciano J; Drabkin Harry; Crawford E David
Woman with a papillary pulmonary lesion and a complex renal cyst.
Oncology (Williston Park, N.Y.) 2006;20(11):1437-9, 1443.
-
2006: Su Xinying; Drabkin Harry; Clappier Emmanuelle; Morgado Ester; Busson Maryvonne; Romana Serge; Soulier Jean; Berger Roland; Bernard Olivier A; Lavau Catherine
Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
Genes, chromosomes & cancer 2006;45(9):846-55.
-
2006: Dohadwala Mariam; Yang Seok-Chul; Luo Jie; Sharma Sherven; Batra Raj K; Huang Min; Lin Ying; Goodglick Lee; Krysan Kostyantyn; Fishbein Michael C; Hong Longsheng; Lai Chi; Cameron Robert B; Gemmill Robert M; Drabkin Harry A; Dubinett Steven M
Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
Cancer research 2006;66(10):5338-45.
-
2006: Clarhaut Jonathan; Roche Joëlle; Drabkin Harry A
Semaphorins in lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(3):203-4.
-
2006: Witta Samir E; Gemmill Robert M; Hirsch Fred R; Coldren Christopher D; Hedman Karla; Ravdel Larisa; Helfrich Barbara; Dziadziuszko Rafal; Chan Daniel C; Sugita Michio; Chan Zeng; Baron Anna; Franklin Wilbur; Drabkin Harry A; Girard Luc; Gazdar Adi F; Minna John D; Bunn Paul A
Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
Cancer research 2006;66(2):944-50.
-
2005: Kusy Sophie; Potiron Vincent; Zeng Chan; Franklin Wilbur; Brambilla Elisabeth; Minna John; Drabkin Harry A; Roche Joëlle
Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene.
Biochimica et biophysica acta 2005;1730(1):66-76.
-
2005: Nasarre Patrick; Constantin Bruno; Drabkin Harry A; Roche Joëlle
[Semaphorins and cancers : an up 'dating']
Médecine sciences : M/S 2005;21(6-7):641-7.
-
2005: Gemmill R M; Zhou M; Costa L; Korch C; Bukowski R M; Drabkin H A
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.
British journal of cancer 2005;92(12):2266-77.
-
2005: Kusy Sophie; Nasarre Patrick; Chan Daniel; Potiron Vincent; Meyronet David; Gemmill Robert M; Constantin Bruno; Drabkin Harry A; Roche Joëlle
Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells.
Neoplasia (New York, N.Y.) 2005;7(5):457-65.
-
2005: Gemmill Robert M; Lee Jason P; Chamovitz Daniel A; Segal Daniel; Hooper Joan E; Drabkin Harry A
Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5.
Oncogene 2005;24(21):3503-11.
-
2005: Nasarre Patrick; Kusy Sophie; Constantin Bruno; Castellani Valérie; Drabkin Harry A; Bagnard Dominique; Roche Joëlle
Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion.
Neoplasia (New York, N.Y.) 2005;7(2):180-9.
-
2004: Salon C; Moro D; Lantuejoul S; Brichon Py P y; Drabkin H; Brambilla C; Brambilla E
E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis.
Human pathology 2004;35(9):1148-55.
-
2004: Roche J; Zeng C; Barón A; Gadgil S; Gemmill R M; Tigaud I; Thomas X; Drabkin H A
Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1059-63.
-
2003: Puig-Kröger Amaya; Sanchez-Elsner Tilman; Ruiz Natividad; Andreu Enrique J; Prosper Felipe; Jensen Uffe B; Gil Juana; Erickson Paul; Drabkin Harry; Groner Yoram; Corbi Angel L
RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements.
Blood 2003;102(9):3252-61.
-
2003: Kusy Sophie; Funkelstein Lydiane; Bourgais David; Drabkin Harry; Rougon Geneviève; Roche Joëlle; Castellani Valérie
Redundant functions but temporal and regional regulation of two alternatively spliced isoforms of semaphorin 3F in the nervous system.
Molecular and cellular neurosciences 2003;24(2):409-18.
-
2003: Ohira Tatsuo; Gemmill Robert M; Ferguson Kevin; Kusy Sophie; Roche Joëlle; Brambilla Elisabeth; Zeng Chan; Baron Anna; Bemis Lynne; Erickson Paul; Wilder Elizabeth; Rustgi Anil; Kitajewski Jan; Gabrielson Edward; Bremnes Roy; Franklin Wilbur; Drabkin Harry A
WNT7a induces E-cadherin in lung cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(18):10429-34.
-
2003: Lantuéjoul Sylvie; Constantin Bruno; Drabkin Harry; Brambilla Christian; Roche Joëlle; Brambilla Elisabeth
Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
The Journal of pathology 2003;200(3):336-47.
-
2003: Nasarre Patrick; Constantin Bruno; Rouhaud Lydie; Harnois Thomas; Raymond Guy; Drabkin Harry A; Bourmeyster Nicolas; Roche Joëlle
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading.
Neoplasia (New York, N.Y.) 2003;5(1):83-92.
-
2002: de Guzman Cristina G; Warren Alan J; Zhang Zheng; Gartland Larry; Erickson Paul; Drabkin Harry; Hiebert Scott W; Klug Christopher A
Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.
Molecular and cellular biology 2002;22(15):5506-17.
-
2002: Gemmill Robert M; Bemis Lynne T; Lee Jason P; Sozen M Ali; Baron Anna; Zeng Chan; Erickson Paul F; Hooper Joan E; Drabkin Harry A
The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway.
Oncogene 2002;21(22):3507-16.
-
2002: Bremnes R M; Veve R; Gabrielson E; Hirsch F R; Baron A; Bemis L; Gemmill R M; Drabkin H A; Franklin W A
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2417-28.
-
2002: Drabkin H A; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger S P; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(2):186-95.
-
2002: Roche Joëlle; Drabkin Harry; Brambilla Elisabeth
Neuropilin and its ligands in normal lung and cancer.
Advances in experimental medicine and biology 2002;515():103-14.
-
2001: Roche J; Drabkin H A
The role of semaphorins in lung cancer.
Clinical lung cancer 2001;3(2):145-50.
-
2001: Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman M I; Gazdar A F; Minna J D
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(24):13954-9.
-
2001: Varella-Garcia M; Hogan C J; Odom L F; Murata-Collins J L; Ai H; Chen L; Richkind K; Paskulin G; Andreeff M; Brizard A; McGavran L; Gemmill R M; Berger R; Drabkin H A
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(9):1408-14.
-
2001: Dahéron L; Veinstein A; Brizard F; Drabkin H; Lacotte L; Guilhot F; Larsen C J; Brizard A; Roche J
Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23).
Genes, chromosomes & cancer 2001;31(4):382-9.
-
2001: Ueda M; Gemmill R M; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin H A
Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
British journal of cancer 2001;85(1):64-8.
-
2000: Calvo R; West J; Franklin W; Erickson P; Bemis L; Li E; Helfrich B; Bunn P; Roche J; Brambilla E; Rosell R; Gemmill R M; Drabkin H A
Altered HOX and WNT7A expression in human lung cancer.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(23):12776-81.
-
2000: Keith R L; Miller Y E; Gemmill R M; Drabkin H A; Dempsey E C; Kennedy T C; Prindiville S; Franklin W A
Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1616-25.
-
2000: Brambilla E; Constantin B; Drabkin H; Roche J
Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration.
The American journal of pathology 2000;156(3):939-50.
-
2000: Sugita M; Tanaka N; Davidson S; Sekiya S; Varella-Garcia M; West J; Drabkin H A; Gemmill R M
Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung.
Cancer genetics and cytogenetics 2000;117(1):9-18.
-
2000: Calvo R; Drabkin H A
Embryonic genes in cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 3():207-18.
-
1999: Korch C; Drabkin H
Improved DNA sequencing accuracy and detection of heterozygous alleles using manganese citrate and different fluorescent dye terminators.
Genome research 1999;9(6):588-95.
-
1999: de Castro F; Hu L; Drabkin H; Sotelo C; Chédotal A
Chemoattraction and chemorepulsion of olfactory bulb axons by different secreted semaphorins.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(11):4428-36.
-
1999: Drabkin H A; West J D; Hotfilder M; Heng Y M; Erickson P; Calvo R; Dalmau J; Gemmill R M; Sablitzky F
DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC.
Oncogene 1999;18(16):2589-97.
-
1999: Varella-Garcia M; Brizard F; Roche J; Flandrin G; Drabkin H; Brizard A
Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17).
Leukemia & lymphoma 1999;33(3-4):403-6.
-
1999: Hirsch E; Hu L J; Prigent A; Constantin B; Agid Y; Drabkin H; Roche J
Distribution of semaphorin IV in adult human brain.
Brain research 1999;823(1-2):67-79.
-
1999: Korch C; Drabkin H
Manganese citrate improves base-calling accuracy in DNA sequencing reactions using rhodamine-based fluorescent dye-terminators.
Nucleic acids research 1999;27(5):1405-7.
-
1998: Varella-Garcia M; Gemmill R M; Rabenhorst S H; Lotto A; Drabkin H A; Archer P A; Franklin W A
Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
Cancer research 1998;58(20):4701-7.
-
1998: Gemmill R M; West J D; Boldog F; Tanaka N; Robinson L J; Smith D I; Li F; Drabkin H A
The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(16):9572-7.
-
1998: Yokomizo A; Tindall D J; Drabkin H; Gemmill R; Franklin W; Yang P; Sugio K; Smith D I; Liu W
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.
Oncogene 1998;17(4):475-9.
-
1998: Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel M T; Erickson P; Drabkin H; MacLeod R A; Drexler H G; Ghysdael J; Berger R; Bernard O A
Analysis of TEL proteins in human leukemias.
Oncogene 1998;16(22):2895-903.
-
1998: Le Beau M M; Drabkin H; Glover T W; Gemmill R; Rassool F V; McKeithan T W; Smith D I
An FHIT tumor suppressor gene?
Genes, chromosomes & cancer 1998;21(4):281-9.
-
1998: Paskulin G A; Philips G; Morgan R; Sandberg A; Richkind K; Borovik C; McGavran L; Rabinovich N; Dietz-Band J; Erickson P; Drabkin H; Varella-Garcia M
Pre-clinical evaluation of probes to detect t(8;21) AML minimal residual disease by fluorescence in situ hybridization.
Genes, chromosomes & cancer 1998;21(2):144-51.
-
1997: Grebe S K; McIver B; Hay I D; Wu P S; Maciel L M; Drabkin H A; Goellner J R; Grant C S; Jenkins R B; Eberhardt N L
Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 1997;82(11):3684-91.
-
1997: David G; Abbas N; Stevanin G; Dürr A; Yvert G; Cancel G; Weber C; Imbert G; Saudou F; Antoniou E; Drabkin H; Gemmill R; Giunti P; Benomar A; Wood N; Ruberg M; Agid Y; Mandel J L; Brice A
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.
Nature genetics 1997;17(1):65-70.
-
1997: Piemontese M R; Memeo E; Carella M; Amati P; Chomel J C; Bonneau D; Pilia G; Cao A; Drabkin H; Gemmill R; Rommens J; Zelante L; Gasparini P; Bisceglia L
A YAC contig spanning the blepharophimosis-ptosis-epicanthus inversus syndrome and propionic acidemia loci.
European journal of human genetics : EJHG 1997;5(3):171-4.
-
1997: Todd S; Franklin W A; Varella-Garcia M; Kennedy T; Hilliker C E; Hahner L; Anderson M; Wiest J S; Drabkin H A; Gemmill R M
Homozygous deletions of human chromosome 3p in lung tumors.
Cancer research 1997;57(7):1344-52.
-
1997: Boldog F; Gemmill R M; West J; Robinson M; Robinson L; Li E; Roche J; Todd S; Waggoner B; Lundstrom R; Jacobson J; Mullokandov M R; Klinger H; Drabkin H A
Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.
Human molecular genetics 1997;6(2):193-203.
-
1997: Wiest J S; Franklin W A; Otstot J T; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain J W; Anderson M W
Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
Cancer research 1997;57(1):1-6.
-
1997: Wiest J S; Franklin W A; Drabkin H; Gemmill R; Sidransky D; Anderson M W
Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Journal of cellular biochemistry. Supplement 1997;28-29():64-73.
-
1996: David G; Giunti P; Abbas N; Coullin P; Stevanin G; Horta W; Gemmill R; Weissenbach J; Wood N; Cunha S; Drabkin H; Harding A E; Agid Y; Brice A
The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus.
American journal of human genetics 1996;59(6):1328-36.
-
1996: Erickson P F; Dessev G; Lasher R S; Philips G; Robinson M; Drabkin H A
ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Blood 1996;88(5):1813-23.
-
1996: Rassool F V; Le Beau M M; Shen M L; Neilly M E; Espinosa R; Ong S T; Boldog F; Drabkin H; McCarroll R; McKeithan T W
Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2.
Genomics 1996;35(1):109-17.
-
1996: Roche J; Boldog F; Robinson M; Robinson L; Varella-Garcia M; Swanton M; Waggoner B; Fishel R; Franklin W; Gemmill R; Drabkin H
Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.
Oncogene 1996;12(6):1289-97.
-
1996: Franklin W A; Todd S; Gemmill R M; Drabkin H A; Cook R; Sorenson J; Folkvord J; Haney J; Low R; Parks T; Proudfoot S; Kennedy T; Miller Y E
Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokers.
Chest 1996;109(3 Suppl):26S.
-
1996: Song W J; Van Keuren M L; Drabkin H A; Cypser J R; Gemmill R M; Kurnit D M
Assignment of the human slow twitch skeletal muscle/cardiac troponin C gene (TNNC1) to human chromosome 3p21.3-->3p14.3 using somatic cell hybrids.
Cytogenetics and cell genetics 1996;75(1):36-7.
-
1996: Naylor S L; Carritt B; Boileau C; Beroud C; Alexander C; Allderdice P; Alimov A; Ashworth T; Bonifas J; Bugert P; Buys C H; Chipperfield M A; Deng G; Drabkin H; Gemmill R M; Grompe M; Joensuu T; Jonasdottir A; Gizatullin R; Krols L; Leach R J; Lott S T; Killary A; Martinsson T; Messiaen L
Report of the sixth international workshop on human chromosome 3 mapping 1995.
Cytogenetics and cell genetics 1996;72(4):255-70.
-
1995: Pekarsky Y; Zabarovsky E; Kashuba V; Drabkin H; Sandberg A A; Morgan R; Rynditch A; Gardiner K
Cloning of breakpoints in 3q21 associated with hematologic malignancy.
Cancer genetics and cytogenetics 1995;80(1):1-8.
-
1995: van den Berg A; van der Veen A Y; Hulsbeek M M; Kovacs G; Gemmill R M; Drabkin H A; Buys C H
Defining the position of the breakpoint of the constitutional t(3;6) occurring in a family with renal cell carcinoma.
Genes, chromosomes & cancer 1995;12(3):224-8.
-
1995: Todd S; Roche J; Hahner L; Bolin R; Drabkin H A; Gemmill R M
YAC contigs covering an 8-megabase region of 3p deleted in the small-cell lung cancer cell line U2020.
Genomics 1995;25(1):19-28.
-
1995: Sakamoto M; Pinkel D; Mascio L; Sudar D; Peters D; Kuo W L; Yamakawa K; Nakamura Y; Drabkin H; Jericevic Z
Semiautomated DNA probe mapping using digital imaging microscopy: II. System performance.
Cytometry 1995;19(1):60-9.
-
1995: Drabkin H A; Erickson P
Down syndrome and leukemia, an update.
Progress in clinical and biological research 1995;393():169-76.
-
1995: George A L; Varkony T A; Drabkin H A; Han J; Knops J F; Finley W H; Brown G B; Ward D C; Haas M
Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 3p21.
Cytogenetics and cell genetics 1995;68(1-2):67-70.
-
1995: Smith D I; Glover T W; Gemmill R; Drabkin H; O'Connell P; Naylor S L
Report and abstracts of the fifth international workshop on human chromosome 3 mapping 1994. Ann Arbor, Michigan, May 8-9, 1994.
Cytogenetics and cell genetics 1995;68(3-4):125-46.
-
1995: Cotter P D; Drabkin H A; Varkony T; Smith D I; Bishop D F
Assignment of the human housekeeping delta-aminolevulinate synthase gene (ALAS1) to chromosome band 3p21.1 by PCR analysis of somatic cell hybrids.
Cytogenetics and cell genetics 1995;69(3-4):207-8.
-
1994: Leach R J; Chinn R; Reus B E; Hayes S; Schantz L; Dubois B; Overhauser J; Ballabio A; Drabkin H; Lewis T B
Regional localization of 188 sequence tagged sites on a somatic cell hybrid mapping panel for human chromosome 3.
Genomics 1994;24(3):549-56.
-
1994: Boldog F L; Waggoner B; Glover T W; Chumakov I; Le Paslier D; Cohen D; Gemmill R M; Drabkin H A
Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B.
Genes, chromosomes & cancer 1994;11(4):216-21.
-
1994: Wilke C M; Guo S W; Hall B K; Boldog F; Gemmill R M; Chandrasekharappa S C; Barcroft C L; Drabkin H A; Glover T W
Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma.
Genomics 1994;22(2):319-26.
-
1994: Todd S; Naylor S L; Drabkin H A; Gemmill R M
Dinucleotide repeat polymorphism (D3S1776) on human chromosome 3p.
Human molecular genetics 1994;3(5):841.
-
1994: Klauck S M; Whisenant E; Wood M; Drabkin H A; Seizinger B R
Dinucleotide repeat polymorphism at the D3S1255 locus.
Human molecular genetics 1994;3(5):840.
-
1994: Erickson P F; Robinson M; Owens G; Drabkin H A
The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.
Cancer research 1994;54(7):1782-6.
-
1994: Roche J; Whisenant E; Boldog F; Loeb D; Vance J M; Drabkin H
Dinucleotide repeats flanking the renal carcinoma breakpoint at 3p14.2.
Human molecular genetics 1994;3(1):215.
-
1993: Smith S E; Joseph A; Nadeau S; Shridhar V; Gemmill R; Drabkin H; Knuutila S; Smith D I
Cloning and characterization of the human t(3;6)(p14;p11) translocation breakpoint associated with hematologic malignancies.
Cancer genetics and cytogenetics 1993;71(1):15-21.
-
1993: Boldog F L; Gemmill R M; Wilke C M; Glover T W; Nilsson A S; Chandrasekharappa S C; Brown R S; Li F P; Drabkin H A
Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8509-13.
-
1993: Nucifora G; Begy C R; Erickson P; Drabkin H A; Rowley J D
The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(16):7784-8.
-
1993: Liu W; Piechocki M; Shridhar V; Lyles G; Song Z; Nakamura Y; Drabkin H; Vance J; Smith D I
The isolation of a yeast artificial chromosome (YAC) contig extending for 2 megabases in the vicinity of the von Hippel Lindau disease gene.
Human molecular genetics 1993;2(8):1177-82.
-
1993: Downing J R; Head D R; Curcio-Brint A M; Hulshof M G; Motroni T A; Raimondi S C; Carroll A J; Drabkin H A; Willman C; Theil K S
An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation.
Blood 1993;81(11):2860-5.
-
1993: Pericak-Vance M A; Nunes K J; Whisenant E; Loeb D B; Small K W; Stajich J M; Rimmler J B; Yamaoka L H; Smith D I; Drabkin H A
Genetic mapping of dinucleotide repeat polymorphisms and von Hippel-Lindau disease on chromosome 3p25-26.
Journal of medical genetics 1993;30(6):487-91.
-
1993: Nucifora G; Birn D J; Espinosa R; Erickson P; LeBeau M M; Roulston D; McKeithan T W; Drabkin H; Rowley J D
Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis.
Blood 1993;81(10):2728-34.
-
1993: Chang K S; Fan Y H; Stass S A; Estey E H; Wang G; Trujillo J M; Erickson P; Drabkin H
Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia.
Oncogene 1993;8(4):983-8.
-
1993: Glesne D; Collart F; Varkony T; Drabkin H; Huberman E
Chromosomal localization and structure of the human type II IMP dehydrogenase gene (IMPDH2).
Genomics 1993;16(1):274-7.
-
1993: Nucifora G; Birn D J; Erickson P; Gao J; LeBeau M M; Drabkin H A; Rowley J D
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia.
Blood 1993;81(4):883-8.
-
1993: Jacob C O; Mykytyn K; Varcony T; Drabkin H A
Mapping of the interleukin 5 receptor gene to human chromosome 3 p25-p26 and to mouse chromosome 6 close to the Raf-1 locus with polymorphic tandem repeat sequences.
Mammalian genome : official journal of the International Mammalian Genome Society 1993;4(8):435-9.
-
1993: Heppell-Parton A C; Daly M C; Drabkin H A; Rabbitts P H
The probe BMS1271 identifies a new polymorphic locus (D3S1207) and maps to 3p26-pter.
Cytogenetics and cell genetics 1993;63(1):64-5.
-
1992: Erickson P; Gao J; Chang K S; Look T; Whisenant E; Raimondi S; Lasher R; Trujillo J; Rowley J; Drabkin H
Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.
Blood 1992;80(7):1825-31.
-
1992: Drabkin H A; Mendez M J; Rabbitts P H; Varkony T; Bergh J; Schlessinger J; Erickson P; Gemmill R M
Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020.
Genes, chromosomes & cancer 1992;5(1):67-74.
-
1992: Morishita K; Parganas E; William C L; Whittaker M H; Drabkin H; Oval J; Taetle R; Valentine M B; Ihle J N
Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(9):3937-41.
-
1992: Wood S; Schertzer M; Drabkin H; Patterson D; Longmire J L; Deaven L L
Characterization of a human chromosome 8 cosmid library constructed from flow-sorted chromosomes.
Cytogenetics and cell genetics 1992;59(4):243-7.
-
1991: Gemmill R M; Varella-Garcia M; Smith D I; Erickson P; Golembieski W; Miller Y; Coyle-Morris J; Tommerup N; Drabkin H A
A 2.5-Mb physical map within 3p21.1 spans the breakpoint associated with Greig cephalopolysyndactyly syndrome.
Genomics 1991;11(1):93-102.
-
1991: Smith D I; Liu W; Ginzinger D; Green P; Smith S; Wang N D; Recchia F; Carolyn K; Drabkin H; Golembieski W
Localization of 616 human chromosome 3-specific cosmids using a somatic cell hybrid deletion mapping panel.
Genomics 1991;11(1):179-87.
-
1991: Golembieski W A; Smith S E; Recchia F; Judge A; Shridhar V; Miller O J; Drabkin H; Smith D I
Isolation of large numbers of chromosome 3-specific cosmids containing clusters of rare restriction-endonuclease sites.
American journal of human genetics 1991;49(3):581-9.
-
1991: Barletta C; Druck T; LaForgia S; Calabretta B; Drabkin H; Patterson D; Croce C M; Huebner K
Chromosome locations of the MYB related genes, AMYB and BMYB.
Cancer research 1991;51(14):3821-4.
-
1991: Gao J; Erickson P; Gardiner K; Le Beau M M; Diaz M O; Patterson D; Rowley J D; Drabkin H A
Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(11):4882-6.
-
1991: Gao J Z; Erickson P; Patterson D; Jones C; Drabkin H
Isolation and regional mapping of NotI and EagI clones from human chromosome 21.
Genomics 1991;10(1):166-72.
-
1991: Gemmill R M; Drabkin H A
Report of the Second International Workshop on Human Chromosome 3 mapping.
Cytogenetics and cell genetics 1991;57(4):162-6.
-
1990: Drabkin H; Wright M; Jonsen M; Varkony T; Jones C; Sage M; Gold S; Morse H; Mendez M; Erickson P
Development of a somatic cell hybrid mapping panel and molecular probes for human chromosome 3.
Genomics 1990;8(3):435-46.
-
1990: Miller Y E; Drabkin H; Jones C; Fisher J H
Human aminoacylase-1: cloning, regional assignment to distal chromosome 3p21.1, and identification of a cross-hybridizing sequence on chromosome 18.
Genomics 1990;8(1):149-54.
-
1990: Weber J L; May P E; Patterson D; Drabkin H; Killary A M
Dinucleotide repeat polymorphism at the D3S196 locus.
Nucleic acids research 1990;18(15):4635.
-
1990: Weber J L; Kwitek A E; May P E; Patterson D; Drabkin H
Dinucleotide repeat polymorphisms at the D8S85, D8S87, and D8S88 loci.
Nucleic acids research 1990;18(13):4038.
-
1989: Smith D I; Golembieski W; Drabkin H; Kiousis S
Identification of two cosmids derived from within chromosomal band 3p21.1 that contain clusters of rare restriction sites and evolutionarily conserved sequences.
American journal of human genetics 1989;45(3):443-7.
-
1989: Kiousis S; Drabkin H; Smith D I
Isolation and mapping of a polymorphic DNA sequence (cA476) on chromosome 3 [D3S94]
Nucleic acids research 1989;17(14):5876.
-
1989: Smith D I; Kiousis S; Drabkin H; Wasmuth J
Isolation and mapping of a polymorphic sequence (3UCI 10) on chromosome 3 [D3S8].
Nucleic acids research 1989;17(14):5877.
-
1989: Smith D I; Mangrulker R; Geist R; Gilbert J; Kinsman K; Drabkin H; Golembieski W
Saturation of human chromosome 3 with unique sequence hybridization probes.
Genomics 1989;4(4):453-9.
-
1989: Drabkin H; Sage M; Helms C; Green P; Gemmill R; Smith D; Erickson P; Hart I; Ferguson-Smith A; Ruddle F
Regional and physical mapping studies characterizing the Greig polysyndactyly 3;7 chromosome translocation, t(3;7)(p21.1;p13).
Genomics 1989;4(4):518-29.
-
1989: Gemmill R M; Coyle-Morris J; Ware-Uribe L; Pearson N; Hecht F; Brown R S; Li F P; Drabkin H A
A 1.5-megabase restriction map surrounding MYC does not include the translocation breakpoint in familial renal cell carcinoma.
Genomics 1989;4(1):28-35.
-
1988: Drabkin H; Kao F T; Hartz J; Hart I; Gazdar A; Weinberger C; Evans R; Gerber M
Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(23):9258-62.
-
1988: Gardiner K; Watkins P; Münke M; Drabkin H; Jones C; Patterson D
Partial physical map of human chromosome 21.
Somatic cell and molecular genetics 1988;14(6):623-37.
-
1988: Gerber M J; Drabkin H A; Firnhaber C; Miller Y E; Scoggin C H; Smith D I
Regional localization of chromosome 3-specific DNA fragments by using a hybrid cell deletion mapping panel.
American journal of human genetics 1988;43(4):442-51.
-
1988: Fisher J H; Emrie P A; Drabkin H A; Kushnik T; Gerber M; Hofmann T; Jones C
The gene encoding the hydrophobic surfactant protein SP-C is located on 8p and identifies an EcoRI RFLP.
American journal of human genetics 1988;43(4):436-41.
-
1988: Sacchi N; Cheng S V; Tanzi R E; Gusella J F; Drabkin H A; Patterson D; Haines J H; Papas T S
The ETS genes on chromosome 21 are distal to the breakpoint of the acute myelogenous leukemia translocation (8;21).
Genomics 1988;3(2):110-6.
-
1988: Tantravahi U; Stewart G D; Van Keuren M; McNeil G; Roy S; Patterson D; Drabkin H; Lalande M; Kurnit D M; Latt S A
Isolation of DNA sequences on human chromosome 21 by application of a recombination-based assay to DNA from flow-sorted chromosomes.
Human genetics 1988;79(3):196-202.
-
1988: Mars W M; van Tuinen P; Drabkin H A; White J W; Saunders G F
A myeloid-related sequence that localizes to human chromosome 8q21.1-22.
Blood 1988;71(6):1713-9.
-
1987: Drayna D T; McLean J W; Wion K L; Trent J M; Drabkin H A; Lawn R M
Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily.
DNA (Mary Ann Liebert, Inc.) 1987;6(3):199-204.
-
1987: Harrison G S; Drabkin H A; Kao F T; Hartz J; Hart I M; Chu E H; Wu B J; Morimoto R I
Chromosomal location of human genes encoding major heat-shock protein HSP70.
Somatic cell and molecular genetics 1987;13(2):119-30.
-
1986: Van Keuren M; Drabkin H; Hart I; Harker D; Patterson D; Vora S
Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.
Human genetics 1986;74(1):34-40.
-
1986: Hards R G; Benkovic S J; Van Keuren M L; Graw S L; Drabkin H A; Patterson D
Assignment of a third purine biosynthetic gene (glycinamide ribonucleotide transformylase) to human chromosome 21.
American journal of human genetics 1986;39(2):179-85.
-
1986: Van Keuren M L; Watkins P C; Drabkin H A; Jabs E W; Gusella J F; Patterson D
Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids.
American journal of human genetics 1986;38(6):793-804.
-
1986: Gerber M J; Miller Y E; Drabkin H A; Scoggin C H
Regional assignment of the polymorphic probe D3S3 to 3p14 by molecular hybridization.
Cytogenetics and cell genetics 1986;42(1-2):72-4.
-
1986: Neve R L; Stewart G D; Newcomb P; Van Keuren M L; Patterson D; Drabkin H A; Kurnit D M
Human chromosome 21-encoded cDNA clones.
Gene 1986;49(3):361-9.
-
1985: Drabkin H A
The molecular biology of chromosome alterations in myelogenous leukemia.
The Western journal of medicine 1985;143(6):825-8.
-
1985: Drabkin H A; Bradley C; Hart I; Bleskan J; Li F P; Patterson D
Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(20):6980-4.
-
1985: Diaz M O; Le Beau M M; Rowley J D; Drabkin H A; Patterson D
The role of the c-mos gene in the 8;21 translocation in human acute myeloblastic leukemia.
Science (New York, N.Y.) 1985;229(4715):767-9.
-
1985: Drabkin H A; Diaz M; Bradley C M; Le Beau M M; Rowley J D; Patterson D
Isolation and analysis of the 21q+ chromosome in the acute myelogenous leukemia 8;21 translocation: evidence that c-mos is not translocated.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(2):464-8.
-
1985: Patterson D; van Keuren M; Drabkin H; Watkins P; Gusella J; Scoggin C
Molecular analysis of chromosome 21 using somatic cell hybrids.
Annals of the New York Academy of Sciences 1985;450():109-20.
Sign-in to see more